查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
動物傳染病診斷市場——增長、趨勢、COVID-19 的影響和預測 (2023-2028)
市場調查報告書
商品編碼
1273508

動物傳染病診斷市場——增長、趨勢、COVID-19 的影響和預測 (2023-2028)

Veterinary Infectious Disease Diagnostics Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，獸醫傳染病診斷市場預計將以 7.5% 的複合年增長率增長。

在 COVID-19 大流行期間，獸醫傳染病診斷市場受到了一定程度的影響，因為大多數國家和州都將寵物護理/動物護理視為一項基本服務。 因此，在大流行期間增長並未明顯放緩。 大多數國家/地區將獸醫醫院視為必不可少的業務，這使它們能夠在與大流行相關的限制和關閉的情況下繼續提供服務。 然而，在大流行的頭幾個月，一些獸醫醫院和診所發現許多關鍵地區的寵物護理合規性有所下降。 但隨著封鎖解除，獸醫服務在一定程度上恢復了。 例如，AmerisourceBergen Corporation 2020 報告稱，自 2020 年 12 月以來，許多動物醫院服務已顯示出顯著改善的跡象。 此外，大流行導致寵物收養激增，例如，保險研究委員會 2020 年 10 月的一份報告稱，在 COVID-19 大流行期間，近三分之一的美國人 (30%) 失去了一隻寵物。收養了一個孩子. 2021 年 3 月，根據美國寵物用品協會的數據，美國約有 67% 的家庭擁有寵物，代表約 8490 萬戶家庭。 寵物擁有量的增加預計將很快增加對動物傳染病診斷的採購和需求。

推動市場增長的某些因素包括先進動物診斷設備的日益普及、寵物保險需求的增加以及伴侶動物數量的增加。 北美寵物健康保險協會 (NAPHIA) 表示，2020 年，美國的寵物健康保險顯示總保費為 19.9 億美元。 從 2016 年到 2020 年，該市場的複合年增長率約為 24.2%。 2020年12月，投保寵物總數達到340萬隻。

根據 NAPHIA 的數據，北美大約有 20 家寵物保險公司。 隨著寵物保險的增加，主人越來越傾向於帶他們的寵物進行診斷測試。 同樣，人畜共患疾病的興起也是增加診斷檢測以防止疾病傳播的重要原因。 根據世界自然基金會 2020 年 8 月發表的一篇研究論文，60.3% 的新發疾病是人畜共患的。

此外，大多數傳染病起源於野生動物，然後傳播給伴侶動物和人類。 這是亞太地區面臨的主要挑戰之一，因為大多數人畜共患疾病都起源於亞太地區。 一個典型的例子是 COVID-19。 在歐洲，許多國家製定了支持伴侶動物的有利立法。 著名的例子包括 2014 年法國國民議會委員會法、2012 年捷克共和國民法典、2006 年英國動物福利法、2004 年奧地利憲法、2002 年德國憲法和 2002 年 10 月 4 日的瑞士法案。 這些法律導致了對動物診斷的有利方法，推動了它們數量的積極增長。 因此，家庭和農場中伴侶動物的增加有望在預測期內為市場帶來正增長。

因此，由於上述因素，該市場有望在分析期內實現增長。 然而，寵物護理的高成本可能會阻礙市場增長。

獸醫傳染病診斷市場趨勢

免疫診斷領域預計在預測期內增長

該細分市場的主導地位主要是由於免疫測定在傳染病檢測中的使用越來越多、新型檢測的開發、自動化趨勢的增加、健康和健身意識的提高以及與設備相關的並發症的減少等因素造成的，這些因素包括：作為

例如，根據 2021 年 5 月版臨床微生物學手冊，免疫測定可適用於檢測實驗室中跨學科的分析物，並且通常比其他診斷方法更具成本效益。 在臨床微生物學實驗室中，免疫測定通常用作確認測試。 因此，免疫測定結果通常不作為診斷的唯一依據。 但對於某些傳染病如萊姆病、隱球菌性腦膜炎、梅毒等，免疫法檢測抗體和抗原是確診感染的主要手段。 免疫測定法因其易用性、快速性和通常的高特異性而越來越多地用於即時檢測。

以前，獸醫感染/病原體的診斷已使用多種技術進行，包括□聯免疫吸附測定 (ELISA)、中和、瓊脂凝膠免疫擴散和補體固定，使用抗體和它依賴於檢測病原體的方法由文化。 然而，近年來，改進的基於免疫測定的診斷測試已經發展到以更高的準確性和更少的時間和精力取代傳統方法。 例如，2021 年 4 月，為分子和免疫獸醫測試開發完整解決方案的全球領導者 INDICAL 從勃林格殷格翰手中收購了 Svanova 產品組合。 這通過作為目標抗原的特定蛋白質的生產得到增強，並且通過新的和先進的生物技術技術（例如基因克隆和表達載體的使用）使之成為可能。 由於這些因素，預計市場將在預測期內增長。

此外，研究合作的增加、實驗室的增加以及製藥和生物技術公司對研發 (R&D) 的直接和間接投資增加等因素增加了產品需求，推動了未來幾年的市場增長。支持增長。

獸醫傳染病診斷市場-IMG1

北美有望主導脫毛器市場

由於寵物保險的增加、伴侶動物的增加以及該地區可用的先進診斷設備，預計北美將在全球獸醫傳染病診斷市場中佔據重要的市場份額。 根據美國寵物用品協會 2020-2021 年的調查，大約有 6520 萬戶家庭養狗，4330 萬戶養貓，580 萬戶養鳥，530 萬戶養小動物，180 萬戶養馬。我來了。 由於人與動物的相互作用增加，人畜共患疾病迅速傳播，因此數量的增加將需要更多的診斷測試。 根據美國寵物用品協會 2020-2021 年的研究，美國家養犬的平均年基本費用為外科獸醫 429 美元和定期檢查 213 美元。 這使 2020-2021 年美國寵物行業總支出達到約 823.1 億美元。 支出的增加表明寵物主人願意對他們的寵物進行診斷測試。 由於這些因素，預計未來幾年市場將出現顯著增長。

此外，不斷增加的研發活動和有利的醫療保健基礎設施的存在極大地促進了整個區域市場的增長。 例如，2021 年 9 月，國際傳染病學會（聯合國的一部分）在傳染病的不同領域提供各種資助。 大部分資金用於動物的傳染病診斷。 同樣，美國通過 2010 年 10 月與動物疾病診斷研究培訓中心（烏克蘭）簽署的一項長期協議，資助該地區的臨床研究（特別是動物健康研究、診斷和培訓）。 由於這些因素，預計市場將在預測期內進入增長期。

獸醫傳染病診斷市場-IMG2

獸醫傳染病診斷行業概況

獸醫傳染病診斷市場適度整合，少數主要參與者競爭激烈。 就市場份額而言，目前少數大公司佔據市場主導地位。 目前主導市場的公司包括 Biomerieux S.A.、Heska Corporation、IDEXX Laboratories, Inc.、IDVet、Indical Bioscience、Neogen Corporation、Randox Laboratories, Ltd.、Thermo Fisher Scientific Inc、Virbac 和 Zoetis, Inc.。

其他福利：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 調查先決條件
  • 本次調查的範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 先進的獸醫診斷設備
    • 對寵物保險的需求不斷增長
    • 伴侶動物數量增加
  • 市場製約因素
    • 寵物護理費用高
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 按技術
    • 免疫診斷學
    • 分子診斷
    • 其他
  • 動物類型
    • 伴侶動物
    • 食用動物
  • 按傳染病類型
    • 細菌感染
    • 病毒感染
    • 寄生蟲感染
    • 其他
  • 最終用戶
    • 參考實驗室
    • 動物實驗室/診所
    • 護理點/內部測試
    • 其他
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲
      • 乙拉吉爾
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Biomerieux S.A.
    • Heska Corporation
    • IDEXX Laboratories, Inc.
    • IDVet
    • Indical Bioscience
    • Neogen Corporation
    • Randox Laboratories, Ltd.
    • Thermo Fisher Scientific Inc.
    • Virbac
    • Zoetis, Inc.

第七章市場機會與未來趨勢

簡介目錄
Product Code: 72257

The Veterinary Infectious Disease Diagnostics Market is projected to register a CAGR of 7.5% during the forecast period.

During the COVID-19 pandemic, the veterinary infectious disease diagnostics market was moderately affected, as most countries and their states treat pet care/ animal care as an essential service. Therefore, the growth wasn't significantly declined during the pandemic. Since most countries treat veterinary practices as essential businesses, this allows the services to remain open even during pandemic-related restrictions and shutdowns. Still, some veterinary hospitals and clinics experienced a drop in pet care compliance in many key areas during the first few months of the pandemic. However, veterinary services resumed to some extent as the lockdown lifted. For instance, AmerisourceBergen Corporation 2020 reported that since December 2020, many veterinary services had shown signs of significant improvement. Moreover, the pandemic has seen a surge in pet adoption; for instance, according to the Insurance Research Council's October 2020 report, during the COVID-19 pandemic, nearly one in three (30 percent) of Americans adopted a pet. In March 2021, According to American Pet Products Association, around 67% of United States households own a pet, which is about 84.9 million homes. This increase in pet adoption is expected to increase the procurement and demand for veterinary infectious disease diagnoses soon.

Certain factors that are driving the market growth include increasing advanced diagnostic devices for animals, growing demand for pet insurance, and an increasing companion animal population. The North American Pet Health Insurance Association (NAPHIA) states that in 2020, pet health insurance for the United States showed gross written premiums of USD 1.99 billion. The market has been growing at an average annual growth rate of around 24.2% from 2016 to 2020. In December 2020, the total number of pets insured reached 3.4 million.

According to NAPHIA, around 20 pet insurance companies are in the North American region. With the increase in pet insurance, owners are more likely to take their pets for diagnostic testing. Similarly, the rise in zoonotic diseases is also one of the key reasons to increase diagnostic tests as it prevents diseases from spreading. According to the world wildlife fund research paper published in August 2020, 60.3% of all new emerging diseases are zoonoses.

Additionally, most infectious diseases originate in wildlife and are further spread to the companion animals and humans. This is one of the key issues in the Asia Pacific region, as most of the zoonotic diseases originate from the region. One of the notable examples is COVID-19. In Europe, many countries have favorable laws to support companion animals. The Commission Laws of the French National Assembly in 2014, the Czech Republic Civil Code of 2012, the United Kingdom Animal Welfare Act of 2006, the Austrian Constitution in 2004, the German Constitution in 2002, and Switzerland's Law of October 4, 2002, are a few notable examples. Due to these laws, there is a favorable approach to the diagnosis of animals, which incites a positive growth in the number of these animals. Hence, the increasing number of companion animals in households and farms will show positive growth for the market during the forecast period.

Therefore, owing to the aforementioned factors, the studied market is anticipated to witness growth over the analysis period. However, high pet care costs is likely to impede market growth.

Veterinary Infectious Disease Diagnostics Market Trends

The Immunodiagnostics segment is Expected to Witness Growth Over the Forecast Period

The dominance of this segment is mainly attributed to factors such as the increasing use of immunoassays in infectious disease testing, the development of novel tests, the rising trend of automation, increasing awareness about health and fitness, and reduce complications associated with the instruments.

For instance, in May 2021, as per the Manual of Clinical Microbiology, 11th Edition, immunoassays can be adapted for detecting analytes across laboratory disciplines and are often more cost-effective than other diagnostic methods. In the clinical microbiology laboratory, immunoassays often serve as confirmatory tests. Therefore, the results are typically not intended to be used as the sole basis for a diagnosis. However, for certain infectious diseases, including Lyme disease, cryptococcal meningitis, and syphilis, antibody and antigen detection by immunoassays is the primary means by which the infection is established. Due to their ease of use, rapid turnaround time, and generally high specificity, immunoassays are increasingly becoming available for point-of-care testing.

Earlier, the diagnostics for veterinary infectious diseases/pathogens have relied on methods for detecting the pathogen by antibodies or culture, using various techniques, such as Enzyme-linked Immunosorbent Assay (ELISA), neutralization, agar gel immunodiffusion, and complement fixation. However, in the past few years, improved immunoassay-based diagnostics tests have evolved and have replaced the more traditional methods, resulting in improved accuracy while requiring less time and effort. For instance, in April 2021, INDICAL, a global leader in developing complete solutions for molecular and immunological veterinary testing, acquired the Svanova product portfolio from Boehringer Ingelheim. This is enhanced by the production of specific proteins which serve as target antigen and makes it possible with new advanced biotechnological methods, such as the cloning of genes and the use of expression vectors. Due to these factors, the market will grow during the forecast period.

Furthermore, factors such as growing research collaborations, an increasing number of research laboratories, and growing direct and indirect investments in research and development (R&D) by pharmaceutical and biotechnology companies will increase product demand, fueling the market's growth in the coming years.

Veterinary Infectious Disease Diagnostics Market - IMG1

North America is Expected to Dominate the Hair Removal Devices Market

North America is expected to hold a major market share in the global veterinary infectious disease diagnostics market due to rising pet insurance, increased companion animals, and advanced diagnostic devices available in the region. According to the American Pet Products Association survey 2020-2021, around 65.2 million households own dogs, 43.3 million own cats, 5.8 million own birds, 5.3 million own small animals, and 1.8 million own horses, among others. This increasing number requires more diagnostic tests as zoonotic diseases can spread quickly due to more human and animal interactions. According to the American Pet Products Association survey 2020-2021, the basic annual expenses for dogs in an average United States household come to USD 429 for a Surgical vet and USD 213 for a routine visit. This puts the total United States pet industry expenditures around USD 82.31 billion in 2020-2021. The rise in expenditure shows a willingness in owners to go for diagnostic tests with their pets. Due to these factors, the market will show significant growth in the upcoming years.

Moreover, an increase in research and development activities and the presence of favorable healthcare infrastructure are fueling the growth of the overall regional market to a large extent. For instance, in September 2021, the International Society for Infectious Diseases (part of the United Nations) provides various grants in different fields of infectious diseases. Many of the grants are offered to veterinary infectious diagnostics. Similarly, the United States has a long-term agreement with Research Training Center for Animal Disease Diagnostics (Ukraine) which was signed on October 2010 to provide funding for clinical research (specifically for research, diagnostics, and training for animal health) in that region. Due to these factors, the market will see a growth period during the forecast period.

Veterinary Infectious Disease Diagnostics Market - IMG2

Veterinary Infectious Disease Diagnostics Industry Overview

The Veterinary Infectious Disease Diagnostics Market is moderately consolidated and competitive and consists of a few major players. In terms of market share, a few of the major players are currently dominating the market. Some companies currently dominating the market are Biomerieux S.A., Heska Corporation, IDEXX Laboratories, Inc., IDVet, Indical Bioscience, Neogen Corporation, Randox Laboratories, Ltd., Thermo Fisher Scientific Inc., Virbac and Zoetis, Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Advanced Diagnostic Devices for Animals
    • 4.2.2 Growing Demand for Pet Insurance
    • 4.2.3 Increasing Companion Animal Population
  • 4.3 Market Restraints
    • 4.3.1 High Pet Care Costs
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Technology
    • 5.1.1 Immunodiagnostics
    • 5.1.2 Molecular Diagnostics
    • 5.1.3 Others
  • 5.2 By Animal Type
    • 5.2.1 Companion Animals
    • 5.2.2 Food Producing Animals
  • 5.3 By Infection Type
    • 5.3.1 Bacterial Infections
    • 5.3.2 Viral Infections
    • 5.3.3 Parasitic Infections
    • 5.3.4 Others
  • 5.4 By End User
    • 5.4.1 Reference Laboratories
    • 5.4.2 Veterinary Laboratories and Clinics
    • 5.4.3 Point of Care/In House Testing
    • 5.4.4 Others
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Biomerieux S.A.
    • 6.1.2 Heska Corporation
    • 6.1.3 IDEXX Laboratories, Inc.
    • 6.1.4 IDVet
    • 6.1.5 Indical Bioscience
    • 6.1.6 Neogen Corporation
    • 6.1.7 Randox Laboratories, Ltd.
    • 6.1.8 Thermo Fisher Scientific Inc.
    • 6.1.9 Virbac
    • 6.1.10 Zoetis, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS